|
1
|
Fleischmann WR Jr, Kleyn KM and Baron S:
Potentiation of antitumor effect of virus-induced interferon by
mouse immune interferon preparations. J Natl Cancer Inst.
65:963–966. 1980.PubMed/NCBI
|
|
2
|
Randall RE and Goodbourn S: Interferons
and viruses: an interplay between induction, signalling, antiviral
responses and virus countermeasures. J Gen Virol. 89:1–47. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baron S, Hernandez J, Bekisz J, et al:
Clinical model: interferons activate human monocytes to an
eradicative tumor cell level in vitro. J Interferon Cytokine Res.
27:157–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu YJ: IPC: professional type 1
interferon-producing cells and plasmacytoid dendritic cell
precursors. Annu Rev Immunol. 23:275–306. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schoenborn JR and Wilson CB: Regulation of
interferon-gamma during innate and adaptive immune responses. Adv
Immunol. 96:41–101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cantell K and Hirvonen S: Large-scale
production of human leukocyte interferon containing 10(8) units per
ml. J Gen Virol. 39:541–543. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cantell K and Hirvonen S: Preparation of
human leukocyte interferon for clinical use. Tex Rep Biol Med.
35:138–144. 1977.PubMed/NCBI
|
|
8
|
Radaeva S, Jaruga B, Hong F, et al:
Interferon-alpha activates multiple STAT signals and down-regulates
c-Met in primary human hepatocytes. Gastroenterology.
122:1020–1034. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang CJ, Xiao CW, You TG, et al:
Interferon-alpha enhances antitumor activities of oncolytic
adenovirus-mediated IL-24 expression in hepatocellular carcinoma.
Mol Cancer. 11:312012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jelkmann W: Erythropoietin: structure,
control of production and function. Physiol Rev. 72:449–489.
1992.PubMed/NCBI
|
|
11
|
Lacombe C, Da Silva JL, Bruneval P, et al:
Identification of tissues and cells producing erythropoietin in the
anemic mouse. Contrib Nephrol. 66:17–24. 1988.PubMed/NCBI
|
|
12
|
Neumann E: Regulation of erythropoiesis.
Acta Med Austriaca Suppl. 6:360–363. 1979.(In German).
|
|
13
|
Argenti M: Hematosis and erythropoiesis in
guinea pigs exposed to low oxygen pressure. Riv Med Aeronaut.
14:283–313. 1951.(In Italian).
|
|
14
|
Radtke HW, Claussner A, Erbes PM,
Scheuermann EH, Schoeppe W and Koch KM: Serum erythropoietin
concentration in chronic renal failure: relationship to degree of
anemia and excretory renal function. Blood. 54:877–884.
1979.PubMed/NCBI
|
|
15
|
Fisher JW: Mechanism of the anemia of
chronic renal failure. Nephron. 25:106–111. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McGonigle RJ, Wallin JD, Shadduck RK and
Fisher JW: Erythropoietin deficiency and inhibition of
erythropoiesis in renal insufficiency. Kidney Int. 25:437–444.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baneyx F: Recombinant protein expression
in Escherichia coli. Curr Opin Biotechnol. 10:411–421. 1999.
View Article : Google Scholar
|
|
18
|
Houdebine LM: Transgenic animal
bioreactors. Transgenic Res. 9:305–320. 2000. View Article : Google Scholar
|
|
19
|
Lubo H and Palmer C: Transgenic animal
bioreactors - where we are. Transgenic Res. 9:301–304. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bühler TA, Bruyère T, Went DF, Stranzinger
G and Burki K: Rabbit beta-casein promoter directs secretion of
human interleukin-2 into the milk of transgenic rabbits.
Biotechnology (NY). 8:140–143. 1990.PubMed/NCBI
|
|
21
|
Cerdan MG, Young JI, Zino E, et al:
Accurate spatial and temporal transgene expression driven by a
3.8-kilobase promoter of the bovine beta-casein gene in the
lactating mouse mammary gland. Mol Reprod Dev. 49:236–245. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ebert KM, DiTullio P, Barry CA, et al:
Induction of human tissue plasminogen activator in the mammary
gland of transgenic goats. Biotechnology (NY). 12:699–702. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gordon K, Lee E, Vitale JA, Smith AE,
Westphal H and Hennighausen L: Production of human tissue
plasminogen activator in transgenic mouse milk. 1987.
Biotechnology. 24:425–428. 1992.PubMed/NCBI
|
|
24
|
Ikonen T, Ojala M and Ruottinen O:
Associations between milk protein polymorphism and first lactation
milk production traits in Finnish Ayrshire cows. J Dairy Sci.
82:1026–1033. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hennighausen LG, Sippel AE, Hobbs AA and
Rosen JM: Comparative sequence analysis of the mRNAs coding for
mouse and rat whey protein. Nucleic Acids Res. 10:3733–3744. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Malewski T and Zwierzchowski L:
Computer-aided analysis of potential transcription-factor binding
sites in the rabbit beta-casein gene promoter. Biosystems.
36:109–119. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rosen JM, Wyszomierski SL and Hadsell D:
Regulation of milk protein gene expression. Annu Rev Nutr.
19:407–436. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Raught B, Liao WS and Rosen JM:
Developmentally and hormonally regulated CCAAT/enhancer-binding
protein isoforms influence beta-casein gene expression. Mol
Endocrinol. 9:1223–1232. 1995.PubMed/NCBI
|
|
29
|
Buser AC, Gass-Handel EK, Wyszomierski SL,
et al: Progesterone receptor repression of prolactin/signal
transducer and activator of transcription 5-mediated transcription
of the beta-casein gene in mammary epithelial cells. Mol
Endocrinol. 21:106–125. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Doppler W, Windegger M, Soratroi C, et al:
Expression level-dependent contribution of glucocorticoid receptor
domains for functional interaction with STAT5. Mol Cell Biol.
21:3266–3279. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zinovieva N, Lassnig C, Schams D, et al:
Stable production of human insulin-like growth factor 1 (IGF-1) in
the milk of hemi- and homozygous transgenic rabbits over several
generations. Transgenic Res. 7:437–447. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Coulibaly S, Besenfelder U, Fleischmann M,
et al: Human nerve growth factor beta (hNGF-beta): mammary gland
specific expression and production in transgenic rabbits. FEBS
Lett. 444:111–116. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Devinoy E, Thépot D, Stinnakre MG, et al:
High level production of human growth hormone in the milk of
transgenic mice: the upstream region of the rabbit whey acidic
protein (WAP) gene targets transgene expression to the mammary
gland. Transgenic Res. 3:79–89. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng CK, Hoo RL, Chow BK and Leung PC:
Functional cooperation between multiple regulatory elements in the
untranslated exon 1 stimulates the basal transcription of the human
GnRH-II gene. Mol Endocrinol. 17:1175–1191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee GS, Choi KC, Han HJ and Jeung EB: The
classical and a non-classical pathways associated with NF-kappaB
are involved in estrogen-mediated regulation of calbindin-D9k gene
in rat pituitary cells. Mol Cell Endocrinol. 277:42–50. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song S and Oka T: Regulation of type II
deiodinase expression by EGF and glucocorticoid in HC11 mouse
mammary epithelium. Am J Physiol Endocrinol Metab. 284:E1119–E1124.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jung EM, Kim YK, Lee GS, Hyun SH, Hwang WS
and Jeung EB: Establishment of inducible cAMP early repressor
transgenic fibroblasts in a porcine model of human type 1 diabetes
mellitus. Mol Med Report. 6:239–245. 2012.PubMed/NCBI
|
|
38
|
Kim YK, Lee GS, Jung EM, Hyun SH, Hwang WS
and Jeung EB: Generation of fibroblasts overexpressing
liver-specific PEPCK in a miniature pig model of human type 2
diabetes mellitus. Mol Med Report. 6:45–50. 2012.PubMed/NCBI
|
|
39
|
Houdebine LM: Production of pharmaceutical
proteins by transgenic animals. Comp Immunol Microbiol Infect Dis.
32:107–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hodges CA and Stice SL: Generation of
bovine transgenics using somatic cell nuclear transfer. Reprod Biol
Endocrinol. 1:812003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Riego E, Limonta J, Aguilar A, et al:
Production of transgenic mice and rabbits that carry and express
the human tissue plasminogen activator cDNA under the control of a
bovine alpha S1 casein promoter. Theriogenology. 39:1173–1185.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kuss AW, Gogol J, Bartenschlager H and
Geldermann H: Polymorphic AP-1 binding site in bovine CSN1S1 shows
quantitative differences in protein binding associated with milk
protein expression. J Dairy Sci. 88:2246–2252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chessa S, Chiatti F, Ceriotti G, et al:
Development of a single nucleotide polymorphism genotyping
microarray platform for the identification of bovine milk protein
genetic polymorphisms. J Dairy Sci. 90:451–464. 2007. View Article : Google Scholar
|
|
44
|
Houdebine LM, Teyssot B, Djiane J and
Devinoy E: Control of the expression of milk protein genes by
prolactin, glucocorticoids and progesterone. Ann Endocrinol
(Paris). 43:354–369. 1982.(In French).
|
|
45
|
Pierre S, Jolivet G, Devinoy E, et al: A
distal region enhances the prolactin induced promoter activity of
the rabbit alpha s1-casein gene. Mol Cell Endocrinol. 87:147–156.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shingo T, Gregg C, Enwere E, et al:
Pregnancy-stimulated neurogenesis in the adult female forebrain
mediated by prolactin. Science. 299:117–120. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kamel MA, Neulen J, Sayed GH, Salem HT and
Breckwoldt M: Heterogeneity of human prolactin levels in serum
during the early postpartum period. Gynecol Endocrinol. 7:173–177.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Orru MG, Baita A, Sitzia R, et al:
Interferon-alpha-induced psychiatric side effects in patients with
chronic viral hepatitis: a prospective, observational, controlled
study. Epidemiol Psichiatr Soc. 14:145–153. 2005.(In Italian).
|
|
49
|
Ferrantini M, Capone I and Belardelli F:
Interferon-alpha and cancer: mechanisms of action and new
perspectives of clinical use. Biochimie. 89:884–893. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Oster W, Herrmann F, Gamm H, et al:
Erythropoietin for the treatment of anemia of malignancy associated
with neoplastic bone marrow infiltration. J Clin Oncol. 8:956–962.
1990.PubMed/NCBI
|
|
51
|
Son YD, Jeong YT, Park SY and Kim JH:
Enhanced sialylation of recombinant human erythropoietin in Chinese
hamster ovary cells by combinatorial engineering of selected genes.
Glycobiology. 21:1019–1028. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tuite MF, Dobson MJ, Roberts NA, et al:
Regulated high efficiency expression of human interferon-alpha in
Saccharomyces cerevisiae. EMBO J. 1:603–608. 1982.PubMed/NCBI
|
|
53
|
Wall RJ, Kerr DE and Bondioli KR:
Transgenic dairy cattle: genetic engineering on a large scale. J
Dairy Sci. 80:2213–2224. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zuelke KA: Transgenic modification of cows
milk for value-added processing. Reprod Fertil Dev. 10:671–676.
1998. View Article : Google Scholar : PubMed/NCBI
|
